(Q34611083)

English

Combining the anti-HER2 antibody trastuzumab with taxanes in breast cancer: results and trial considerations.

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Combining the anti-HER2 antibody trastuzumab with taxanes in breast cancer: results and trial considerations (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit